Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Core Viewpoint - Agios Pharmaceuticals, Inc. is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, highlighting its focus on innovative medicines for rare diseases [1]. Company Overview - Agios Pharmaceuticals is a commercial-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to transforming the treatment of rare diseases through trusted partnerships and innovative medicines [3]. - The company emphasizes a foundation in hematology and aims to advance a growing pipeline of rare disease medicines that align with the needs of the communities it serves [3]. Presentation Details - The live webcast of the presentation will be available on the Investors section of Agios' website, with a replay accessible for at least two weeks post-presentation [2].